Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism　- From the COMMAND VTE Registry.

BACKGROUND It remains controversial whether sex category is a risk for recurrent venous thromboembolism (VTE) and major bleeding among VTE patients.Methods and Results:The COMMAND VTE Registry is a multicenter registry enrolling 3,027 consecutive acute symptomatic VTE patients from 29 centers in Japan between January 2010 and August 2014. We compared the clinical characteristics and outcomes of men and women. Men accounted for 1,169 (39%) and women 1,858 (61%). Compared with women, men were younger (64.9±14.7 vs. 68.6±15.6 years old, P<0.001), more often had prior VTE (7.2% vs. 5.1%, P=0.02), and less often had transient risk factors for VTE (30% vs. 40%, P<0.001). The proportions of active cancer and pulmonary embolism were comparable between men and women (24% vs. 22%, P=0.26; 56% vs. 57%, P=0.48, respectively). The cumulative 3-year incidences of recurrent VTE, major bleeding, and all-cause death were not significantly different between men and women (7.0% vs. 8.6%, P=0.47; 10.6% vs. 9.2%, P=0.25; 25.2% vs. 23.4%, P=0.35, respectively). The adjusted risks of men relative to women for recurrent VTE and for major bleeding remained insignificant (HR 0.83, 95% CI 0.63-1.09, P=0.17; HR 1.15, 95% CI 0.90-1.47, P=0.25, respectively). CONCLUSIONS In real-world VTE patients, the clinical characteristics differed between men and women, but there was not a large sex-related difference in the risks for recurrent VTE or major bleeding.

[1]  S. Haneuse.  Distinguishing Selection Bias and Confounding Bias in Comparative Effectiveness Research , 2016, Medical care.

[2]  Takeshi Kimura,et al.  Anticoagulation Therapy for Venous Thromboembolism in the Real World　- From the COMMAND VTE Registry. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[3]  E. Oger,et al.  Venous thromboembolism (VTE) in Europe , 2007, Thrombosis and Haemostasis.

[4]  Paolo Prandoni,et al.  The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. , 2007, Haematologica.

[5]  J. Kline,et al.  Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). , 2011, Journal of the American College of Cardiology.

[6]  John A. Heit,et al.  The epidemiology of venous thromboembolism , 2003, Journal of Thrombosis and Thrombolysis.

[7]  G. Moneta,et al.  The hemodynamics and diagnosis of venous disease. , 2007, Journal of vascular surgery.

[8]  Piotr Pruszczyk,et al.  Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism , 2008 .

[9]  F. Rosendaal,et al.  Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event , 2010, Journal of thrombosis and haemostasis : JTH.

[10]  G. Lip,et al.  Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism. , 2017, The American journal of cardiology.

[11]  M. Prins,et al.  Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. , 1999, Archives of internal medicine.

[12]  A. Ciampi,et al.  Men had a higher risk of recurrent venous thromboembolism than women: a large population study. , 2012, Gender medicine.

[13]  E. Minar,et al.  The risk of recurrent venous thromboembolism in men and women. , 2004, The New England journal of medicine.

[14]  P. Ridker,et al.  Hormonal factors and risk of recurrent venous thrombosis: the Prevention of Recurrent Venous Thromboembolism trial , 2006, Journal of thrombosis and haemostasis : JTH.

[15]  H. Almodaimegh,et al.  Do women bleed more than men when prescribed novel oral anticoagulants for venous thromboembolism? A sex-based meta-analysis. , 2013, Thrombosis research.

[16]  M. Toyofuku,et al.  Influence of baseline anemia on long-term clinical outcomes in patients with venous thromboembolism: from the COMMAND VTE registry , 2019, Journal of Thrombosis and Thrombolysis.

[17]  Samuel Z Goldhaber,et al.  Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) , 1999, The Lancet.

[18]  R. White,et al.  Racial and gender differences in the incidence of recurrent venous thromboembolism , 2006, Thrombosis and Haemostasis.

[19]  B. Lämmle,et al.  Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study. , 2017, The American journal of medicine.

[20]  F. Rosendaal,et al.  Risk assessment for recurrent venous thrombosis , 2010, The Lancet.

[21]  Jeroen J. Bax,et al.  ESC Guidelines on the diagnosis and management of acute pulmonary embolism , 2014 .

[22]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[23]  G. Raskob,et al.  Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. , 2013, The New England journal of medicine.

[24]  G. Moneta.  Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism: Findings From the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry , 2009 .

[25]  Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[26]  J. Kline,et al.  Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association , 2011, Circulation.

[27]  S. Schulman,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.

[28]  M. Monreal,et al.  Sex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism , 2014, Medicine.

[29]  T. Baglin,et al.  High risk of recurrent venous thromboembolism in men , 2004, Journal of thrombosis and haemostasis : JTH.